Fleroxacin and Glucose Injection

This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.

The main ingredient of this product is fleroxacin.

This product is a colorless, light yellow or light yellow-green clear liquid.

1. It can be used for respiratory system infections such as acute bronchitis, acute exacerbation of chronic bronchitis and pneumonia caused by bacteria sensitive to this product; 2. Urinary and reproductive system infections such as cystitis, pyelonephritis, prostatitis, epididymitis, gonorrhea Neisseria urethritis, etc.; 3. Digestive system infections such as typhoid Salmonella infection and bacterial dysentery; 4. Skin and soft tissue infections, bone infections, abdominal infections and pelvic infections, etc.

Inject slowly by intravenous drip in a dark place, 0.2-0.4 g at a time, once a day.

1. Gastrointestinal reactions are relatively common and may manifest as abdominal discomfort or pain, diarrhea, nausea and vomiting, and loss of appetite. 2. Central nervous system reactions may include dizziness, headache, excitement, drowsiness or insomnia. 3. Allergic reactions include rash, skin itching, and occasionally exudative erythema multiforme and angioneurotic edema. A small number of patients have photosensitivity reactions. 4. A small number of patients may have increased blood aminotransferase and blood urea nitrogen and decreased peripheral white blood cells, which are mostly mild and transient. 5. Occasionally, 5.1 Epileptic seizures, mental abnormalities, irritability, confusion, hallucinations, and tremors may occur. 5.2 Manifestations of interstitial nephritis such as hematuria, fever, and rash. 5.3 Crystalluria, more common when used in high doses. 5.4 Joint pain. 5.5 Phlebitis.

1. Those who are allergic to this product or quinolone drugs are prohibited from using this product. 2. Pregnant women, lactating women and patients under 18 years old are prohibited from using this product.

Precautions for children: 1. Fluoroquinolones can cause permanent damage to the cartilage of the weight-bearing joints of dogs, leading to lameness, and can also cause arthritis in several other underage animals, so they are contraindicated for patients under 18 years old. 2. In infections caused by multidrug-resistant bacteria, when the bacteria are only sensitive to fluoroquinolones, this product can only be used in children after weighing the pros and cons. Precautions for pregnancy and lactation: Fluoroquinolones can pass through the blood-placental barrier and can be secreted into breast milk, and their concentration is close to the blood drug concentration, so they are contraindicated for pregnant and lactating women. Precautions for the elderly: Elderly patients have reduced renal function, and the dosage should be reduced as appropriate.

1. The aluminum and magnesium contained in didanosine (DDI) preparations can chelate with fluoroquinolones and should not be used together. 2. Urine alkalinizers can reduce the solubility of this product in urine, leading to crystalluria and nephrotoxicity. 3. Probenecid can delay the excretion of this product, increase the blood concentration of this product and produce toxicity.

Keep away from light, tightly closed, and stored in a cool and dark place.

100ml: Fleroxacin 0.2g and glucose 5.0g

24 months

Zhejiang Guojing Pharmaceutical Co., Ltd.

• Founded in:

  1997-06-01

• Address:

  No. 9 Kelun Avenue, Lutian Industrial Park, Longquan City, Lishui City, Zhejiang Province

• Tax NO.:

  91331181148543087L

• Registered Funds:

  51.8 million yuan

• Email:

  Log in to view